Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: The right choice in elderly patients

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 9, 2013, Pages 1344-1353

  Berretta, Massimiliano ^a   Aprile, Giuseppe ^b   Nasti, Guglielmo ^c   Urbani, Martina ^a   Bearz, Alessandra ^a   Lutrino, Stefania ^b   Foltran, Luisa ^b   Ferrari, Laura ^b   Talamini, Renato ^a   Fiorica, Francesco ^d   Lleshi, Arben ^a,e   Canzonieri, Vincenzo ^a   Lestuzzi, Chiara ^a   Borsatti, Eugenio ^a   Fisichella, Rossella ^e   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

Author keywords

Chemotherapy; Colorectal cancer; Elderly patients; Oxaliplatin

Indexed keywords

ANTIEMETIC AGENT; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE;

AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SENSORY NEUROPATHY; THROMBOCYTOPENIA; ANALOGS AND DERIVATIVES; COLORECTAL NEOPLASMS; DISEASE COURSE; NEOPLASM METASTASIS; PATHOLOGY; SURVIVAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; MALE; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84888216250     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113136660347     Document Type: Article

References (52)

1. Ferlay, J.; Autier, P.; Boniol, M.; Heanue, M.; Colombet, M.; Boyle, P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol., 2007, 18(3), 581-592.
2. American Cancer Society. Cancer facts and figures, 2006. American Cancer Society; Atlanta: 2006. http://www.cancer.org/acs/groups/content/@nho/documents/document/caff2006pwsecuredpdf.pdf (Accessed April 26, 2011).
3. Gatta, G.; Faivre, J.; Capocaccia, R.; Ponz de Leon, M. Survival of colorectal cancer patients in Europe during period 1978-1989: the EUROCARE Working Group. Eur. J. Cancer, 1998, 34 (14 Spec. No.), 2176-2183.
4. Winawer, S.J.; Fletcher, R.H.; Miller, L.; Godlee, F.; Stolar, M.H.; Mulrow, C.D.; Woolf, S.H.; Glick, S.N.; Ganiats, T.G.; Bond, J.H.; Rosen, L.; Zapka, J.G.; Olsen, S.J.; Giardiello, F.M.; Sisk, J.E.; Van Antwerp, R.; Brown-Davis, C.; Marciniak, D.A.; Mayer, R.J. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 1997, 112, 594-642.
5. Berardi, R.; Saladino, T.; Mari, D.; Silva, R.R.; Scartozzi, M.; Verdecchia, L.; Onofri, A.; Cascinu, S. Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy. Tumori, 2005, 91, 463-466.
6. Folprecht, G.; Seymour MT; Saltz L.; Douillard, J.Y.; Hecker, H.; Stephens, R.J.; Maughan, T.S.; Van Cutsem, E.; Rougier, P.; Mitry, E.; Schubert, U.; Köhne, C.H. Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: Combined analysis of 2691 patients in randomized controlled trials. J. Clin. Oncol., 2008, 26, 1443-1451.
7. Hutchins, L.F.; Unger, J.M.; Crowley, J.J.; Coltman, C.A. Jr.; Albain, K.S. Underrepresentation of patients 65 years age or older in cancer-treatment trials. N. Engl. J. Med., 1999, 341, 2061-2067.
8. Seymour, M.T.; Thompson, L.C.; Wasan, H.S.; Middleton, G.; Brewster, A.E.; Shepherd, S.F.; O'Mahony, M.S.; Maughan, T.S.; Parmar, M.; Langley, R.E.; FOCUS2 Investigators; National Cancer Research Institute Colorectal Cancer Clinical Studies Group. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS 2): an open-label; randomised factorial trial. Lancet, 2011, 377 (9779), 1749-1759.
9. Townsley, C.A.; Selby, R.; Siu, L.L. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J. Clin. Oncol., 2005, 23, 3112-3124.
10. Chiara, S.; Nobile, M.T.; Vincenti, M.; Lionetto, R.; Gozza, A.; Barzacchi, M.C.; Sanguineti, O.; Repetto, L.; Rosso, R. Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy. Cancer Chemother. Pharmacol., 1998, 42, 336-340.
11. Popescu, R.A.; Norman, A.; Ross, P.J.; Parikh, B.; Cunningham, D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J. Clin. Oncol., 1999, 17, 2412-2418.
12. Feliu, J.; Escudero, P.; Llosa, F.; Bolaños, M.; Vicent, J.M.; Yubero, A.; Sanz-Lacalle, J.J.; Lopez, R.; Lopez-Gómez, L.; Casado, E.; Gómez-Reina, M.J.; González-Baron, M. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study. J. Clin. Oncol., 2005, 23, 3104-3111.
13. De Gramont, A.; Figer, M.; Seymour, M.; Homerin, M.; Hmissi, A.; Cassidy, J.; Boni, C.; Cortes-Funes, H.; Cervantes, A.; Freyer, G.; Papamichael, D.; Le Bail, N.; Louvet, C.; Hendler, D.; De Braud, F.; Wilson, C.; Morvan, F.; Bonetti, A. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol., 2000, 18, 2938-2947.
14. Douillard, J.Y.; Cunningham, D.; Roth, A.D.; Navarro, M.; James, R.D.; Karasek, P.; Jandik, P.; Iveson, T.; Carmichael, J.; Alakl, M.; Gruia, G.; Awad, L.; Rougier P. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre radnomised trial. Lancet, 2000, 355, 1041-1057.
15. Goldberg, R.M.; Sargent, D.J.; Morton, R.F.; Fuchs, C.S.; Ramanathan, R.K.; Williamson, S.K.; Findlay, B.P.; Pitot, H.C.; Alberts, S.R. A randomised controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J. Clin. Oncol., 2004, 22, 23-30.
16. Berretta, M.; Cappellani, A.; Fiorica, F.; Nasti, G.; Frustaci, S.; Fisichella, R.; Bearz, A.; Talamini, R.; Lleshi, A.; Tambaro, R.; Cocciolo, A.; Ristagno, M.; Bolognese, A.; Basile, F.; Meneguzzo, N.; Berretta, S.; Tirelli, U. FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients:a prospective study. Arch. Gerontol. Geriatr., 2011, 52(1), 89-93.
17. Berretta, M.; Zanet, E.; Nasti, G.; Lleshi, A.; Frustaci, S.; Fiorica, F.; Bearz, A.; Talamini, R.; Lestuzzi, C.; Lazzarini, R.; Fisichella, R.; Cannizzaro, R.; Iaffaioli, R.V.; Berretta, S.; Tirelli, U. Oxaliplatin-base chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC). Arch. Gerontol. Geriatr., 2011, Sep 19 [E-pub ahead of print].
18. Berretta M.; Bearz A.; Frustaci S.; Talamini R.; Lombardi D.; Fratino L.; Lleshi A.; Bonanno S.; Spartà D.; Palmucci S.; Berretta S.; Tirelli U. Folfox2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients. J. Chemother., 2008, 20, 503-508.
19. Comella P.; Natale D.; Farris A.; Gambardella A.; Maiorino L.; Massidda B.; Casaretti R.; Tafuto S.; Lorusso V.; Leo S.; Cannone M. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108. Cancer, 2005, 104, 282-289.
20. Kim J.H.; Oh D.Y.; Kim Y.J.; Han S.W.; Choi I.S.; Kim D.W.; Im S.A.; Kim T.Y.; Lee J.S.; Heo D.S.; Bang Y.J.; Kim N.K. Reduced dose intensity Folfox-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer. J. Korean. Med. Sci., 2005, 20, 806-810.
21. Sastre J.; Aranda E.; Masutti B.; Tabernero J.; Chaves M.; Abad A.; Carrato A.; Reina JJ.; Queralt B.; Gomez-Esapna A.; Gonzalez-Flores E.; Rivera F.; Losa F.; Garcia T.; Sanchez-Rovira P.; Maestu I.; Diaz-Rubio E. Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study. Crit. Rev. Oncol. Hematol., 2009, 70, 134-144.
22. Goldberg R.M.; Tabah-Fisch I.; Bleiberg H.; De Gramont A.; Tournigand C.; Andre T.; Rothenberg M.L.; Green E.; Sargent D.J. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J. Clin. Oncol., 2006, 24, 4085-4091.
23. Miwa, M.; Ura, M.; Nishida, M.; Sawada, N.; Ishikawa, T.; Mori, K.; Shimma, N.; Umeda, I.; Ishitsuka, H. Design of a novel oral fluoropyrimidine carbamate; capecitabine; which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur. J. Cancer., 1998, 34, 1274-1281.
24. Schuller, J.; Cassidy, J.; Dumont, E.; Roos, B-; Durston, S.; Banken, L.; Utoh, M.; Mori, K.; Weidekamm, E.; Reigner, B. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer. Chemother. Pharmacol., 2000, 45, 291-297.
25. Hoff, P.M.; Ansari, R.; Batist, G.; Cox, J.; Kocha, W.; Kuperminc, M.; Maroun, J.; Walde, D.; Weaver, C.; Harrison, E.; Burger, H.U.; Osterwalder, B.; Wong, A.O.; Wong, R. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J. Clin. Oncol., 2001, 19(8), 2282-2292.
26. Díaz-Rubio, E.; Evans, T.R.; Tabemero, J.; Cassidy, J.; Sastre, J.; Eatock, M.; Bisset, D.; Regueiro, P.; Baselga, J. Capecitabine (Xeloda) in combination with oxaliplatin: a phase I dose-escalation study in patients with advancet or metastatic solid tumors. Ann. Oncol., 2002, 13(4), 558-565.
27. Borner, M.M.; Dietrich, D.; Stupp, R.; Morant, R.; Honegger, H.; Wernli, M.; Herrmann, R.; Pestalozzi, B.C.; Saletti, P.; Hanselmann, S.; Müller, S.; Brauchli, P.; Castiglione-Gertsch, M.; Goldhirsch, A.; Roth, A.D. Phase II study of capecitabine and oxaliplatin in first-and second-line treatment of advance or metastatic colorectal cancer. J. Clin. Oncol., 2002, 20(7), 1759-1766.
28. Zeuli, M.; Nardoni, C.; Pino, M.S.; Gamucci, T.; Gabriele, A.; Ferraresi, V.; Giannarelli, D.; Cognetti, F. Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. Ann. Oncol., 2003, 14(9) 1378-1382.
29. Scheithauer, W.; Kornek, G.V.; Raderer, M.; Schüll, B.; Schmid, K.; Kovats, E.; Schneeweiss, B.; Lang, F.; Lenauer, A.; Depisch, D. Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol., 2003, 21(7), 1307-1312.
30. Porschen, R.; Arkenau, H.T.; Kubicka, S.; Greil, R.; Seufferlein, T.; Freier, W.; Kretzschmar, A.; Graeven, U.; Grothey, A.; Hinke, A.; Schmiegel, W.; Schmoll, H.J.; AIO Colorectal Study Group. Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group. J. Clin. Oncol., 2007, 25(27), 4217-4223.
31. Piccirillo, J.F.; Tierney, R.M.; Costas, I.; Grove, L.; Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. J. Am. Med. Assoc., 2004, 291, 2441-2447.
32. Fiorica, F.; Cartei, F.; Carau, B.; Berretta, S.; Spartà, D.; Tirelli, U.; Santangelo, A.; Maugeri, D.; Luca, S.; Leotta, C.; Sorace, R.; Berretta, M. Adjuvant radiotherapy on older and oldest elderly rectal cancer patients. Arch. Gerontol. Geriatr., 2009, 49(1), 54-59
33. Therasse, P.; Arbuck, S.G.; Eisenhauer, E.A.; Wanders, J.; Kaplan, R.S.; Rubinstein, L.; Verweij, J.; Van Glabbeke, M.; Van Oosterom, A.T.; Christian, M.C.; Gwyther, S.G. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer; National Cancer Institute of the United States; National Cancer Institute of Canada. J. Natl. Cancer. Inst., 2000, 92, 205-216.
34. Blum, J.L.; Jones, S.E.; Buzdar, A.U.; LoRusso, P.; Kuter, I.; Vogel, C.; Osterwalder, B.; Burger, H.U.; Brown, C.S.; Griffin, T. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J. Clin. Oncol., 1999, 17(2), 485-493.
35. National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf (Accessed April 26, 2011).
36. Kaplan, E.L.; Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 1958, 53, 457-481.
37. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer. Chemother. Rep., 1966, 50, 163-170.
38. Armitage P; Berry G. Statistical Methods in Medical Research; Blackwell Sc. Publication: London, 1987.
39. Edwards, B.K.; Brown, M.L.; Wingo, P.A.; Howe, H.L.; Ward, E.; Ries L.A.; Schrag, D.; Jamison, P.M.; Jemal, A.; Wu, X.C.; Friedman, C.; Harlan, L.; Warren, J.; Anderson, R.N.; Pickle, L.W. Annual report to the nation on the status of cancer; 1975-2002; featuring population-based trends in cancer treatment. J. Natl. Cancer Inst., 2005, 97, 1407-1427.
40. Yee, K.W.; Pater, J.L.; Pho, L.; Zee, B.; Siu, L.L. Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier? J. Clin. Oncol., 2003, 21, 1618-1623.
41. Lewis, J.H.; Kilgore, M.L.; Goldman, D.P.; Trimble, E.L., Kaplan, R., Montello, M.J., Housman, M.G., Escarce, J.J. Participation of patients 65 years of age or older in cancer clinical trials. J. Clin. Oncol., 2003, 21, 1383-1389.
42. Honecker, F.; Kohne, C.H.; Bokemeyer, C. Colorectal cancer in the elderly: Is palliative chemotherapy of value? Drugs Aging, 2003, 20, 1-11.
43. Ho, C.; Ng, K.; O'Reilly, S.; Gill, S. Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis. Clin. Colorectal Cancer, 2005, 5, 279-282.
44. Khattak, M.A.; Townsend, A.R.; Beeke, C.; Karapetis, C.S.; Luke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.J. Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer. Eur. J. Cancer., 2012, 48, 1293-1298.
45. Cascinu, S.; Del Ferro, E.; Catalano, G. Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer. Am. J. Clin. Oncol., 1996, 19, 371-374.
46. Figer, A.; Perez-Staub, N.; Carola, E.; Tourningard, C.; Lledo, G.; Flesh, M.; Barcelo, R.; Cervantes, A.; André, T.; Colin, P.; Louvet, C.; De Gramont, A. Folfox in patients aged between 75 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer, 2007, 110, 2666-2671.
47. Sastre, J.; Aranda, E.; Massuti, B.; Tabernero, J.; Chaves, M.; Abad, A.; Carrato, A.; Reina, J.J.; Queralt, B.; Gomez-Espana, A.; Gonzalez-Flores, E.; Rivera, F.; Losa, F.; Garcia, T.; Sanchez-Rovira, P.; Maestu, I.; Diaz-Rubio, E. Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparitive outcomes from the 03-TTD-01 phase III study. Crit. Rev. Oncol. Hematol., 2009, 70, 134-144.
48. Satram-Hoang, S.; Ramanan, D.; Lee, L.F.; Yu, S.; Reyes, C.M.; McKenna E. Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer. J. Clin. Oncol., 2012, 30 (Suppl. 4), abstract 463.
49. Macdonald, J.S. Vive la difference: sex and fluorouracil toxicity. J. Clin. Oncol., 2002, 20, 1439-1441.
50. Vincent, M.; Jonker, D.; Kerr, I.; Kocha, W.; Taylor, M.; Alam, Y.; Malpage, A.; O'Connell, A.; Whiston, F.; Mathews, J. Reduced dose capecitabine monotherapy in older or less fit patients with adevanced colo-rectal cancer (A CR Ca). Proc. Am. Soc. Clin. Oncol., 2003, 22, 323, abstr. 1297.
51. Di Benedetto, F.; Berretta, M.; D'Amico, G.; Montalti, R.; De Ruvo, N.; Cautero, N.; Guerrini, G.P.; Ballarin, R.; Spaggiari, M.; Tarantino, G.; Di Sandro, S; Pecchi, A.; Luppi, G.; Gerunda, G.E. Liver resection for colorectal metastases in older adults: A paired matched analysis. J. Am. Geriatr. Soc., 2011, 59(12), 2282-2290.
52. Balducci, L.; Extermann, M. Management of cancer in the older person: A practical approach. Oncologist, 2000, 5, 224-237.